Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population

• Published in: BMJ open Vol. 13; no. 4; p. e067611
• Main Authors: Tannous, Jonika, Pan, Alan P, Potter, Thomas, Bako, Abdulaziz T, Dlouhy, Katharine, Drews, Ashley, Sostman, Henry Dirk, Vahidy, Farhaan S
• Format: Journal Article
• Language: English
• Published: England British Medical Journal Publishing Group 05.04.2023; BMJ Publishing Group LTD; BMJ Publishing Group
• Series: Original research
• Subjects: Adult; Antibodies, Monoclonal - therapeutic use; Antibodies, Viral; Comorbidity; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 - therapy; COVID-19 Vaccines; Disease; Disease Progression; Emergency medical care; Epidemiology; Ethnicity; Female; Health services utilization; Health surveillance; Hispanic Americans; Humans; Immunization; Infections; Male; Medical records; Monoclonal antibodies; Patients; Post-Acute COVID-19 Syndrome - drug therapy; Post-Acute COVID-19 Syndrome - prevention & control; Public health; Registries; Regression analysis; Retrospective Studies; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; United States > US; COVID-19; Epidemiology; Public health
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2022-067611

ObjectivesWe evaluated the effectiveness of COVID-19 vaccines and monoclonal antibodies (mAbs) against postacute sequelae of SARS-CoV-2 infection (PASC).Design and settingA retrospective cohort study using a COVID-19 specific, electronic medical record-based surveillance and outcomes registry from a...